Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study
A. Marcon (Verona, Italy), P. Marchetti (Verona, Italy), J. Antó (Barcelona, Spain), L. Cazzoletti (Verona, Italy), I. Cerveri (Pavia, Italy), A. Corsico (Pavia, Italy), J. Garcia-Aymerich (Barcelona, Spain), J. Heinrich (Munich, Germany), D. Gislason (Reykjavik, Iceland), R. Jõgi (Tartu, Estonia), A. Johannessen (Bergen, Norway), B. Leynaert (Paris, France), A. Malinovschi (Uppsala, Sweden), I. Pin (Grenoble, France), J. Weyler (Antwerp, Belgium), C. Janson (Uppsala, Sweden), S. Accordini (Verona, Italy), D. Jarvis (London, United Kingdom)
Source: International Congress 2018 – Asthma in children and adults: long-term aspects
Session: Asthma in children and adults: long-term aspects
Session type: Oral Presentation
Number: 295
Disease area: Airway diseases, Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Marcon (Verona, Italy), P. Marchetti (Verona, Italy), J. Antó (Barcelona, Spain), L. Cazzoletti (Verona, Italy), I. Cerveri (Pavia, Italy), A. Corsico (Pavia, Italy), J. Garcia-Aymerich (Barcelona, Spain), J. Heinrich (Munich, Germany), D. Gislason (Reykjavik, Iceland), R. Jõgi (Tartu, Estonia), A. Johannessen (Bergen, Norway), B. Leynaert (Paris, France), A. Malinovschi (Uppsala, Sweden), I. Pin (Grenoble, France), J. Weyler (Antwerp, Belgium), C. Janson (Uppsala, Sweden), S. Accordini (Verona, Italy), D. Jarvis (London, United Kingdom). Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study. 295
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Reducing the decline of FEV1 after a 4-year therapy with montelukast in patients with bronchial asthma Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008
Long-term association of inhaled corticosteroids and long-acting β2 -agonists with lung function decline in asthma: results from the ECRHS II Source: Eur Respir J 2005; 26: Suppl. 49, 220s Year: 2005
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo Source: Eur Respir J 2006; 28: Suppl. 50, 764s Year: 2006
Observational study of inhaled corticosteroid treatment for improved expiratory variability index in steroid-naïve asthmatic children Source: ERJ Open Res, 8 (1) 00499-2021; 10.1183/23120541.00499-2021 Year: 2022
Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience Source: ERJ Open Res, 8 (1) 00014-2022; 10.1183/23120541.00014-2022 Year: 2022
Obesity and the response to inhaled budesonide in patients with asthma Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019 Year: 2020
Role of tiotropium in reducing exacerbations in COPD patients when added to long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS): The OUTPUL study Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013
Inhaled medication use in asthma and COPD Roma/Gypsies patients Source: Eur Respir J 2005; 26: Suppl. 49, 610s Year: 2005
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis Source: Eur Respir J 2004; 23: 552-558 Year: 2004
Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma Year: 2007
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007
Asthma total costs reduction and clinical improvement after inhaled steroid shift to fluticasone propionate during 1 year in patients with moderate to severe asthma Source: Eur Respir J 2002; 20: Suppl. 38, 56s Year: 2002
Meta-analysis of inhaled corticosteroids response in children with asthma. Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019
Severe exacerbations, decline in lung function and inhaled budesonide in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007
Inhaled corticosteroids in COPD: a case in favour Source: Eur Respir J 2009; 34: 10-12 Year: 2009
FEV1 response to albuterol is not affected by inhaled human insulin (Exubera®) use in subjects with mild-to-moderate asthma Source: Eur Respir J 2006; 28: Suppl. 50, 840s Year: 2006
Efficacy of tiotropium Respimat® in adults with moderate asthma, by baseline LTRA use Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015
A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015